Roche announces U.S. collaboration with Pfizer to help patients who test positive for COVID-19
Roche announced it has entered into a U.S. focused collaboration with Pfizer to drive awareness and educate on the importance of timely COVID-19 testing, available treatment options, symptoms and the high-risk factors that can increase the chance of progressing to severe illness.
This collaboration aims to simplify and improve access to health information related to COVID-19. On covid19knowmore.com, a Pfizer website, individuals can learn why early testing is important at symptom onset, which health conditions increase the risk of progressing to severe COVID-19 and what treatment options are available.
The Pilot COVID-19 At-Home Test, distributed in the United States by Roche Diagnostics and manufactured by SD Biosensor, Inc., will now include a QR code that directs individuals to covid19knowmore.com, where they can learn more about COVID-19, including Centers for Disease Control and Prevention guidance on testing and treatment options.
